NO932212L - Polyaminmedikament-harpikskomplekser - Google Patents

Polyaminmedikament-harpikskomplekser

Info

Publication number
NO932212L
NO932212L NO93932212A NO932212A NO932212L NO 932212 L NO932212 L NO 932212L NO 93932212 A NO93932212 A NO 93932212A NO 932212 A NO932212 A NO 932212A NO 932212 L NO932212 L NO 932212L
Authority
NO
Norway
Prior art keywords
drug
cation exchange
resin
polyaminmedikament
resin complex
Prior art date
Application number
NO93932212A
Other languages
English (en)
Other versions
NO932212D0 (no
Inventor
William Joseph Kelleher
Anthony Earl Carpanzano
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of NO932212D0 publication Critical patent/NO932212D0/no
Publication of NO932212L publication Critical patent/NO932212L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er angitt orale farmasøytiske preparater som omfatter et farmakologisk aktivt polyamin-medikament bundet til en kation- bytter-harpiks for å tilveiebringe et medikament-harpikskompleks med et medikament-innhold større enn en amin-ekviva- lent per ekvivalent kationbytter-kapasitet. Medikament- harpikskomplekset er eventuelt dekket med et vannpermeabelt diffusjonsbarriere-overtrekk som er uoppløselig i mage- og tarm-fluider, og tilveiebringer derved en kontrollerbar medikamentfrigivelse under de forhold som påtreffes i mage- og tarm-systemet.
NO93932212A 1990-12-21 1993-06-16 Polyaminmedikament-harpikskomplekser NO932212L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63229090A 1990-12-21 1990-12-21
PCT/US1991/009463 WO1992011038A1 (en) 1990-12-21 1991-12-16 Polyamine drug-resin complexes

Publications (2)

Publication Number Publication Date
NO932212D0 NO932212D0 (no) 1993-06-16
NO932212L true NO932212L (no) 1993-08-20

Family

ID=24534913

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93932212A NO932212L (no) 1990-12-21 1993-06-16 Polyaminmedikament-harpikskomplekser

Country Status (17)

Country Link
EP (1) EP0563294A1 (no)
JP (1) JPH06504059A (no)
CN (1) CN1063221A (no)
AU (1) AU663695B2 (no)
BR (1) BR9107173A (no)
CA (1) CA2098200A1 (no)
CZ (1) CZ119793A3 (no)
FI (1) FI932842A (no)
HU (1) HUT74642A (no)
IE (1) IE914513A1 (no)
MX (1) MX9102753A (no)
MY (1) MY107811A (no)
NO (1) NO932212L (no)
NZ (1) NZ241097A (no)
PT (1) PT99912A (no)
SK (1) SK59493A3 (no)
WO (1) WO1992011038A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005161A1 (en) * 1993-08-13 1995-02-23 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
DE69432867T2 (de) * 1993-11-18 2004-04-22 Sirtex Medical Ltd., Burswood Zubereitung mit gesteuerter freisetzung
ES2097087B1 (es) * 1994-08-01 1997-12-16 Univ Sevilla Sistema de liberacion controlada de morfina y otros farmacos solubles en agua por complejacion con sustancias polimericas.
CA2269679A1 (en) * 1996-12-20 1998-07-02 Warner-Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
KR20020016069A (ko) * 2000-08-24 2002-03-04 민경윤 마크로라이드계 항생제의 경구투여용 조성물 및 이의 제조방법
AU2004270188B8 (en) * 2003-09-03 2010-04-29 Mallinckrodt Inc. Granular sustained release preparation and production thereof
CN100415297C (zh) * 2006-08-28 2008-09-03 浙江大学 基于阳离子交换树脂的锌补充剂的制备方法
CN100411629C (zh) * 2006-08-28 2008-08-20 浙江大学 一种缓释型补铁剂的制备方法
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
WO2015076821A1 (en) * 2013-11-22 2015-05-28 Tris Pharma, Inc. Novel clonidine formulation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
FR2634377B1 (fr) * 1988-06-30 1991-09-27 Cortial Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes

Also Published As

Publication number Publication date
FI932842A0 (fi) 1993-06-18
WO1992011038A1 (en) 1992-07-09
SK59493A3 (en) 1993-11-10
NO932212D0 (no) 1993-06-16
NZ241097A (en) 1994-11-25
CN1063221A (zh) 1992-08-05
HU9301819D0 (en) 1993-09-28
FI932842A (fi) 1993-06-18
MX9102753A (es) 1992-06-30
AU9168791A (en) 1992-07-22
CA2098200A1 (en) 1992-06-21
JPH06504059A (ja) 1994-05-12
CZ119793A3 (en) 1994-01-19
IE914513A1 (en) 1992-07-01
BR9107173A (pt) 1993-11-16
AU663695B2 (en) 1995-10-19
PT99912A (pt) 1993-01-29
MY107811A (en) 1996-06-29
HUT74642A (en) 1997-01-28
EP0563294A1 (en) 1993-10-06

Similar Documents

Publication Publication Date Title
NO932212L (no) Polyaminmedikament-harpikskomplekser
DK546389D0 (da) Farmaceutisk sammensaetning paa enhedsdosisform til peroral administration
NO20053104D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
DE3860550D1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ES2038181T3 (es) Composiciones farmaceuticas de liberacion sostenida en forma de dosificacion oral.
DE59100067D1 (de) Orale arzneimittelformen von pimobendan.
IL135148A0 (en) A polysaccharide conjugate and pharmaceutical compositions containing the same
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
IT8920168A0 (it) Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
DE69620761D1 (de) Pharmazeutisches praeparat auf der basis eines diclofenac-salzes und der verbindung thiocolchicosid
NO911344L (no) Farmasoeytisk preparat med nitroglyserin til perkutan administrering.
ATE321538T1 (de) Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
NO990282L (no) Absorbsjonsforsterker
NO20015480L (no) Mikrogranuler som ikke er löselige i magesaft, fremgangsmåter for å oppnå det samme og farmasöytiske preparater
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
CA2066031A1 (en) Methods for reducing non-target retention of immunoconjugates and metabolites thereof
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DE59501945D1 (de) Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure
CA2190867A1 (en) Methods for reduced renal uptake of antibody fragments
RU93043627A (ru) Фармацевтическая композиция, содержащая комплекс из смолы и полиаминового лекарственного препарата
IT8619431A0 (it) Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono, procedimento per prepararlo e intermedio utile in detto procedimento.
DK1030659T3 (da) Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist
RU97112236A (ru) Способ лечения злокачественных опухолей кости и метастазов в кость остеолитического характера